InDex Pharmaceuticals Revenue

Pharmaceutical Manufacturing • Stockholm, Stockholm County, Sweden • 1-10 Employees

InDex Pharmaceuticals revenue & valuation

Annual revenue	$1,405,713
Revenue per employee	$141,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$4,500,000
Total funding	$201,900

Key Contact at InDex Pharmaceuticals

Christine Dieterich

Director Cmc

Company overview

Headquarters	Berzelius väg 13, Solna, Stockholm County 171 65, SE
Phone number	+46812203850
Websites	indexpharma.com flerie.com
NAICS	3254
SIC	283
Founded	2000
Employees	1-10
Socials

About InDex Pharmaceuticals

InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The company’s lead asset is the drug candidate cobitolimod, which is being evaluated in the phase III study CONCLUDE as a novel treatment of moderate to severe ulcerative colitis – a debilitating, chronic inflammation of the large intestine. InDex has also developed a platform of patent protected discovery stage substances, so called DNA based ImmunoModulatory Sequences (DIMS), with the potential to be used in the treatment of various immunological diseases. InDex is based in Stockholm, Sweden. The company’s shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

InDex Pharmaceuticals has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore InDex Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-05-01	9	$201,900

Funding Insights

$201,900

Total funding amount

$201,900

Most recent funding amount

Number of funding rounds

InDex Pharmaceuticals Tech Stack

Discover the technologies and tools that power InDex Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Twitter Emoji

Font scripts

Cookiebot

Cookie compliance

PHP

Programming languages

Open Graph

Miscellaneous

Vimeo

Video players

Cookie Control

Cookie compliance

WordPress

Blogs

PWA

Miscellaneous

WordPress Multisite

Hosting

Google Maps

Maps

MySQL

Databases

Frequently asked questions

InDex Pharmaceuticals is located in Stockholm, Stockholm County, SE.

You can reach InDex Pharmaceuticals at +46812203850.

InDex Pharmaceuticals generates an estimated annual revenue of $1,405,713. This revenue figure reflects the company's market position and business performance in its industry.

InDex Pharmaceuticals has an estimated valuation of $4,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

InDex Pharmaceuticals was founded in 2000, making it 26 years old. The company has established itself as a significant player in its industry over this time.

InDex Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

InDex Pharmaceuticals has raised a total of $201,900 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at InDex Pharmaceuticals

Christine Dieterich

Director Cmc

4.8

40,000 users